Calcitonin and carcinoembryonic antigen (CEA) have been suggested as biochemical markers for MTC in the National Comprehensive Cancer Network and American Thyroid Association (ATA) Guidelines for Management of MTC [2]. This evidence concerns the gene CALCA and medullary thyroid gland carcinoma.